Static homepage

Dear friends and colleagues,

From the emergence of COVID-19 in 2020 to adapting to the pandemic’s impact in the present, we as healthcare providers need to forge on as our cancer patients need our support in these trying times. In addition, individual therapy and personalised medicine in oncology have leaped swiftly from theory to practice. The treatment of cancer is no longer a fight against a disease in an organ but against cancerous cells that can spread out from the organ. Urologists will further focus on the treatment of the cancerous cells in lieu of surgical extirpation of the organ.

To equip you with relevant contemporary updates on genitourinary cancers, expect no less than outstanding knowledge exchange at the 19th Meeting of the EAU Section of Oncological Urology (ESOU22). Regardless of the COVID-19 outbreak, the meeting’s scientific programme continues to evolve as it does year after year. It is perpetually designed to bolster your clinical practice and patient care, fortifying the ESOU meeting’s standing as an essential, reputable European reference.

Prof. Morgan Rouprêt
Chairman EAU Section of Oncological Urology